中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)9699.4742169.4132575.3721875.6710832.25
营业收入(万元)9699.4742169.4132575.3721875.6710832.25
营业总成本(万元)10416.7645944.1034630.3722834.9211160.47
营业成本(万元)6725.8429574.6624207.7716505.147998.66
净利润(万元)-356.47-1911.57-265.38-177.93206.84
归属于母公司的净利润(万元)-356.47-1988.49-265.38-177.93206.84
营业利润(万元)-373.45-2371.82-714.88-114.87247.69
利润总额(万元)-396.83-2773.25-1089.72-133.33245.22
少数股东损益(万元)----------
基本每股收益(元)-0.03(元)-0.16(元)-0.02(元)-0.01(元)0.02(元)
稀释每股收益(元)-0.03(元)-0.16(元)-0.02(元)-0.01(元)0.02(元)
非经常性损益(万元)238.79737.05768.82618.77--
扣除非经常性损益后净利润(万元)-595.27-2725.54-1034.19-796.70-64.14
总资产(万元)175169.37175824.39174658.97176862.92181886.85
总负债(万元)20273.8420572.3917760.7719877.2821352.82
归属于母公司股东权益合计(万元)154895.53155252.01156898.20156985.64160534.03
股东权益合计(万元)154895.53155252.01156898.20156985.64160534.03
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512654.45
资本公积(万元)62111.0062111.0062111.0062111.0062111.00
未分配利润(万元)73386.8473743.3175466.4275553.8779102.25
经营活动产生的现金流量净额(万元)-2801.0510266.8710912.895995.985214.55
经营活动现金流入小计(万元)7406.3641806.9936398.4324474.5613705.64
经营活动现金流出小计(万元)10207.4231540.1225485.5418478.598491.09
投资活动产生的现金流量净额(万元)11124.24-13987.61-1408.75902.7310603.27
投资活动现金流入小计(万元)34188.7361403.6246314.6826203.3719146.17
投资活动现金流出小计(万元)23064.4975391.2347723.4325300.648542.90
筹资活动产生的现金流量净额(万元)---3257.29-3154.46-3158.34--
筹资活动现金流入小计(万元)----9.155.27--
筹资活动现金流出小计(万元)--3257.293163.613163.61--
期末现金及现金等价物余额(万元)14519.726178.1719429.1916871.4228916.83
最后修改日期2025-04-292025-04-292024-10-292024-08-262024-04-22
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。